vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and Koppers Holdings Inc. (KOP). Click either name above to swap in a different company.
Koppers Holdings Inc. is the larger business by last-quarter revenue ($432.7M vs $236.8M, roughly 1.8× CROSS COUNTRY HEALTHCARE INC). Koppers Holdings Inc. runs the higher net margin — 6.9% vs -35.0%, a 41.9% gap on every dollar of revenue. On growth, Koppers Holdings Inc. posted the faster year-over-year revenue change (-9.3% vs -23.6%). Koppers Holdings Inc. produced more free cash flow last quarter ($28.5M vs $16.1M). Over the past eight quarters, Koppers Holdings Inc.'s revenue compounded faster (-6.7% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Koppers is a global chemical and materials company based in Pittsburgh, Pennsylvania, United States. Its headquarters is an art-deco 1920s skyscraper, the Koppers Tower.
CCRN vs KOP — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $432.7M |
| Net Profit | $-82.9M | $29.7M |
| Gross Margin | — | 25.6% |
| Operating Margin | -30.2% | 11.5% |
| Net Margin | -35.0% | 6.9% |
| Revenue YoY | -23.6% | -9.3% |
| Net Profit YoY | -2109.7% | 391.2% |
| EPS (diluted) | $-2.56 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $236.8M | $432.7M | ||
| Q3 25 | $250.1M | $485.3M | ||
| Q2 25 | $274.1M | $504.8M | ||
| Q1 25 | $293.4M | $456.5M | ||
| Q4 24 | $309.9M | $477.0M | ||
| Q3 24 | $315.1M | $554.3M | ||
| Q2 24 | $339.8M | $563.2M | ||
| Q1 24 | $379.2M | $497.6M |
| Q4 25 | $-82.9M | $29.7M | ||
| Q3 25 | $-4.8M | $23.8M | ||
| Q2 25 | $-6.7M | $16.4M | ||
| Q1 25 | $-490.0K | $-13.9M | ||
| Q4 24 | $-3.8M | $-10.2M | ||
| Q3 24 | $2.6M | $22.8M | ||
| Q2 24 | $-16.1M | $26.8M | ||
| Q1 24 | $2.7M | $13.0M |
| Q4 25 | — | 25.6% | ||
| Q3 25 | 20.4% | 24.1% | ||
| Q2 25 | 20.4% | 22.6% | ||
| Q1 25 | 20.0% | 23.2% | ||
| Q4 24 | — | 17.5% | ||
| Q3 24 | 20.4% | 21.9% | ||
| Q2 24 | 20.8% | 21.6% | ||
| Q1 24 | 20.4% | 19.3% |
| Q4 25 | -30.2% | 11.5% | ||
| Q3 25 | -2.4% | 10.7% | ||
| Q2 25 | -2.1% | 7.7% | ||
| Q1 25 | -0.3% | 5.9% | ||
| Q4 24 | -1.1% | 1.3% | ||
| Q3 24 | 0.9% | 9.0% | ||
| Q2 24 | -5.7% | 10.2% | ||
| Q1 24 | 0.8% | 7.0% |
| Q4 25 | -35.0% | 6.9% | ||
| Q3 25 | -1.9% | 4.9% | ||
| Q2 25 | -2.4% | 3.2% | ||
| Q1 25 | -0.2% | -3.0% | ||
| Q4 24 | -1.2% | -2.1% | ||
| Q3 24 | 0.8% | 4.1% | ||
| Q2 24 | -4.7% | 4.8% | ||
| Q1 24 | 0.7% | 2.6% |
| Q4 25 | $-2.56 | $1.44 | ||
| Q3 25 | $-0.15 | $1.17 | ||
| Q2 25 | $-0.20 | $0.81 | ||
| Q1 25 | $-0.02 | $-0.68 | ||
| Q4 24 | $-0.13 | $-0.47 | ||
| Q3 24 | $0.08 | $1.09 | ||
| Q2 24 | $-0.47 | $1.25 | ||
| Q1 24 | $0.08 | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | — |
| Total DebtLower is stronger | — | $928.3M |
| Stockholders' EquityBook value | $322.8M | $574.0M |
| Total Assets | $449.0M | $1.9B |
| Debt / EquityLower = less leverage | — | 1.62× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $108.7M | — | ||
| Q3 25 | $99.1M | — | ||
| Q2 25 | $81.2M | — | ||
| Q1 25 | $80.7M | — | ||
| Q4 24 | $81.6M | — | ||
| Q3 24 | $64.0M | — | ||
| Q2 24 | $69.6M | — | ||
| Q1 24 | $5.2M | — |
| Q4 25 | — | $928.3M | ||
| Q3 25 | — | $932.9M | ||
| Q2 25 | — | $977.5M | ||
| Q1 25 | — | $989.0M | ||
| Q4 24 | — | $939.5M | ||
| Q3 24 | — | $989.4M | ||
| Q2 24 | — | $1.0B | ||
| Q1 24 | — | $877.6M |
| Q4 25 | $322.8M | $574.0M | ||
| Q3 25 | $408.1M | $545.6M | ||
| Q2 25 | $412.2M | $526.8M | ||
| Q1 25 | $418.2M | $498.0M | ||
| Q4 24 | $419.0M | $488.7M | ||
| Q3 24 | $424.7M | $532.3M | ||
| Q2 24 | $433.3M | $509.2M | ||
| Q1 24 | $462.4M | $505.8M |
| Q4 25 | $449.0M | $1.9B | ||
| Q3 25 | $538.2M | $1.9B | ||
| Q2 25 | $553.8M | $1.9B | ||
| Q1 25 | $576.2M | $1.9B | ||
| Q4 24 | $589.3M | $1.9B | ||
| Q3 24 | $597.4M | $2.0B | ||
| Q2 24 | $602.9M | $1.9B | ||
| Q1 24 | $648.4M | $1.8B |
| Q4 25 | — | 1.62× | ||
| Q3 25 | — | 1.71× | ||
| Q2 25 | — | 1.86× | ||
| Q1 25 | — | 1.99× | ||
| Q4 24 | — | 1.92× | ||
| Q3 24 | — | 1.86× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | — | 1.74× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $45.1M |
| Free Cash FlowOCF − Capex | $16.1M | $28.5M |
| FCF MarginFCF / Revenue | 6.8% | 6.6% |
| Capex IntensityCapex / Revenue | 0.9% | 3.8% |
| Cash ConversionOCF / Net Profit | — | 1.52× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $67.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $18.2M | $45.1M | ||
| Q3 25 | $20.1M | $49.6M | ||
| Q2 25 | $4.2M | $50.5M | ||
| Q1 25 | $5.7M | $-22.7M | ||
| Q4 24 | $24.2M | $74.7M | ||
| Q3 24 | $7.5M | $29.8M | ||
| Q2 24 | $82.4M | $27.2M | ||
| Q1 24 | $6.0M | $-12.3M |
| Q4 25 | $16.1M | $28.5M | ||
| Q3 25 | $17.9M | $37.6M | ||
| Q2 25 | $2.3M | $38.4M | ||
| Q1 25 | $3.8M | $-37.0M | ||
| Q4 24 | $21.7M | $56.1M | ||
| Q3 24 | $6.3M | $14.4M | ||
| Q2 24 | $79.6M | $10.1M | ||
| Q1 24 | $3.8M | $-38.6M |
| Q4 25 | 6.8% | 6.6% | ||
| Q3 25 | 7.2% | 7.7% | ||
| Q2 25 | 0.8% | 7.6% | ||
| Q1 25 | 1.3% | -8.1% | ||
| Q4 24 | 7.0% | 11.8% | ||
| Q3 24 | 2.0% | 2.6% | ||
| Q2 24 | 23.4% | 1.8% | ||
| Q1 24 | 1.0% | -7.8% |
| Q4 25 | 0.9% | 3.8% | ||
| Q3 25 | 0.9% | 2.5% | ||
| Q2 25 | 0.7% | 2.4% | ||
| Q1 25 | 0.6% | 3.1% | ||
| Q4 24 | 0.8% | 3.9% | ||
| Q3 24 | 0.4% | 2.8% | ||
| Q2 24 | 0.8% | 3.0% | ||
| Q1 24 | 0.6% | 5.3% |
| Q4 25 | — | 1.52× | ||
| Q3 25 | — | 2.08× | ||
| Q2 25 | — | 3.08× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 1.31× | ||
| Q2 24 | — | 1.01× | ||
| Q1 24 | 2.23× | -0.95× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
KOP
| Other | $127.8M | 30% |
| Railroad Treated Products | $119.0M | 28% |
| Utility Poles | $79.8M | 18% |
| Pitch And Related Products | $74.1M | 17% |
| Carbon Black Feedstock And Distillates | $14.4M | 3% |
| Railroad Infrastructure Products And Services | $9.9M | 2% |
| Phthalic Anhydride Naphthalene And Other Chemicals | $7.7M | 2% |
